CI
33
-3
ADT
33
-4
WY
45
-3
LRCX
61
-4
NVDA
52
-2
HSY
44
6
SJM
23
2
EW
55
14
XEL
55
2
KR
63
6
PFG
30
-3
VRSK
66
3
HBAN
53
-3
DNB
56
-2
WU
32
2
FOX
60
7
LB
1
-8
K
53
2
MAC
65
-2
UPS
53
2
CI
33
-3
ADT
33
-4
WY
45
-3
LRCX
61
-4
NVDA
52
-2
HSY
44
6
SJM
23
2
EW
55
14
XEL
55
2
KR
63
6
PFG
30
-3
VRSK
66
3
HBAN
53
-3
DNB
56
-2
WU
32
2
FOX
60
7
LB
1
-8
K
53
2
MAC
65
-2
UPS
53
2
Financhill
Back

BMO Short-Term US TIPS ETF (USD Units) Vs. Aligos Therapeutics Industry Stock Comparison

Sell
46

ZTIP.U.TO
BMO Short-Term US TIPS ETF (USD Units)

Last Price:
29.40
Seasonality Move:
-0.28%
Buy
72

ALGS
Aligos Therapeutics

Last Price:
33.28
Seasonality Move:
10.65%
Sell
46
BMO Short-Term US TIPS ETF (USD Units) (ZTIP.U.TO) is a Sell

Is BMO Short-Term US TIPS ETF (USD Units) a Buy, Sell or Hold?

  • The current BMO Short-Term US TIPS ETF (USD Units) [ZTIP.U.TO] share price is $29.40. The Score for ZTIP.U.TO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • ZTIP.U.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $33.11. The Score for ALGS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ZTIP.U.TO Stock Price Chart

What is BMO Short-Term US TIPS ETF (USD Units)'s stock price today?

  • The BMO Short-Term US TIPS ETF (USD Units) share price today is $29.40
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZTIP.U.TO is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $33.11
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.

ZTIP.U.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 77.77 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.25 - 29.37) Buy
Bollinger Bands (100): (29.19 - 29.39) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.85 Buy
Relative Strength Index (14 RSI): 78.88 Buy
Chaikin Money Flow: -127407 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.12 - 28.52) Buy
Bollinger Bands (100): (7.57 - 20.11) Buy

ZTIP.U.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.33 Buy
20-day SMA: 29.3 Buy
50-day SMA: 29.33 Buy
200-day SMA: 29.08 Buy
8-day EMA: 29.35 Buy
20-day EMA: 29.32 Buy
50-day EMA: 29.32 Buy
200-day EMA: 29.14 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.4 Buy
20-day SMA: 24.33 Buy
50-day SMA: 15.25 Buy
200-day SMA: 15.91 Buy
8-day EMA: 29.74 Buy
20-day EMA: 24.86 Buy
50-day EMA: 18.75 Buy
200-day EMA: 16.3 Buy

BMO Short-Term US TIPS ETF (USD Units) Earnings Growth & ZTIP.U.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

BMO Short-Term US TIPS ETF (USD Units) Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):